SCHEMBL13875969

SCHEMBL13875969

CC(C)(C)C(=O)c1ccnc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 1/20 0.44
▸ TAS1R1 Q7RTX1 1/20 0.44
▸ TAS1R2 Q8TE23 1/20 0.44
▸ PFKFB3 Q16875 1/20 0.40
▸ BRAF P15056 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.36
▸ KDM6B O15054 2/20 0.36
▸ KDM5C P41229 2/20 0.36
▸ KDM4C Q9H3R0 2/20 0.36
▸ KDM2A Q9Y2K7 2/20 0.36
▸ KDM3A Q9Y4C1 2/20 0.36
▸ TET3 O43151 1/20 0.36
▸ KDM4A O75164 1/20 0.36
▸ BBOX1 O75936 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ KDM5A P29375 1/20 0.36
▸ ASPH Q12797 1/20 0.36
▸ KDM4D Q6B0I6 1/20 0.36
▸ TET2 Q6N021 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24198770 0.83 TAS1R3 (0.41) TAS1R3TAS1R1TAS1R2PFKFB3BRAF
SCHEMBL16722814 0.81 KDM5C (0.50) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL13876012 0.79 ALDH1A1 (0.37) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL18212371 0.79 UHRF1 (0.43) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL29967026 0.79 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2PFKFB3BRAF
SCHEMBL1437180 0.79 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2PFKFB3BRAF
SCHEMBL24198772 0.78 TAS1R3 (0.38) TAS1R3TAS1R1TAS1R2PFKFB3BRAF
SCHEMBL15114397 0.78 TAS1R3 (0.44) TAS1R3TAS1R1TAS1R2KDM4EKDM6B
SCHEMBL10819643 0.78 GABRP (0.61) KDM4EKDM6BKDM5CKDM4CKDM2A
SCHEMBL14263091 0.77 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2PFKFB3BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11225505-B2 Antimicrobial polymyxin derivative compounds MONASH UNIVERSITY (AU) 2022-01-18 — — US disclosed
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 — — US disclosed
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11225505-B2 Antimicrobial polymyxin derivative compounds VIP, PNKP, PEPD TAS1R3 3926/4885TAS1R1 4287/4885TAS1R2 4336/4885
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors EPHX1, EPHX2, NCEH1 TAS1R3 4692/4885TAS1R1 4729/4885TAS1R2 4747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback